3D-printed titanium cages without bone graft outperform PEEK cages with autograft in an animal model.
Additive manufacturing
Interbody cages
Interbody fusion
Three-dimensional printing
Titanium
Journal
The spine journal : official journal of the North American Spine Society
ISSN: 1878-1632
Titre abrégé: Spine J
Pays: United States
ID NLM: 101130732
Informations de publication
Date de publication:
06 2022
06 2022
Historique:
received:
22
06
2021
revised:
29
11
2021
accepted:
06
12
2021
pubmed:
16
12
2021
medline:
25
5
2022
entrez:
15
12
2021
Statut:
ppublish
Résumé
Modernization of 3D printing has allowed for the production of porous titanium interbody cages (3D-pTi) which purportedly optimize implant characteristics and increase osseointegration; however, this remains largely unstudied in vivo. To compare osseointegration of three-dimensional (3D) titanium cages without bone graft and Polyether-ether-ketone (PEEK) interbody cages with autologous iliac crest bone graft (AICBG). Animal study utilizing an ovine in vivo model of lumbar fusion. Interbody cages of PEEK or 3D-pTi supplied by Spineart SA (Geneva, Switzerland) were implanted in seven living sheep at L2-L3 and L4-L5, leaving the intervening disc space untreated. Both implant materials were used in each sheep and randomized to the aforementioned disc spaces. Computed tomography (CT) was obtained at 4 weeks and 8 weeks. MicroCT and histological sections were obtained to evaluate osseointegration. MicroCT demonstrated osseous in-growth of native cancellous bone in the trabecular architecture of the 3D-pTi interbody cages and no interaction between the PEEK cages with the surrounding native bone. Qualitative histology revealed robust osseointegration in 3D-pTi implants and negligible osseointegration with localized fibrosis in PEEK implants. Evidence of intramembranous and endochondral ossification was apparent with the 3D-pTi cages. Quantitative histometric bone implant contact demonstrated significantly more contact in the 3D-pTi implants versus PEEK (p<.001); region of interest calculations also demonstrated significantly greater osseous and cartilaginous interdigitation at the implant-native bone interface with the 3D-pTi cages (p=.008 and p=.015, respectively). 3D-pTi interbody cages without bone graft outperform PEEK interbody cages with AICBG in terms of osseointegration at 4 and 8 weeks postoperatively in an ovine lumbar fusion model. 3D-pTi interbody cages demonstrated early and robust osseointegration without any bone graft or additive osteoinductive agents. This may yield early stability in anterior lumbar arthrodesis and potentially bolster the rate of successful fusion. This could be of particular advantage in patients with spinal neoplasms needing post-ablative arthrodesis, where local autograft use would be ill advised.
Sections du résumé
BACKGROUND CONTEXT
Modernization of 3D printing has allowed for the production of porous titanium interbody cages (3D-pTi) which purportedly optimize implant characteristics and increase osseointegration; however, this remains largely unstudied in vivo.
PURPOSE
To compare osseointegration of three-dimensional (3D) titanium cages without bone graft and Polyether-ether-ketone (PEEK) interbody cages with autologous iliac crest bone graft (AICBG).
STUDY DESIGN
Animal study utilizing an ovine in vivo model of lumbar fusion.
METHODS
Interbody cages of PEEK or 3D-pTi supplied by Spineart SA (Geneva, Switzerland) were implanted in seven living sheep at L2-L3 and L4-L5, leaving the intervening disc space untreated. Both implant materials were used in each sheep and randomized to the aforementioned disc spaces. Computed tomography (CT) was obtained at 4 weeks and 8 weeks. MicroCT and histological sections were obtained to evaluate osseointegration.
RESULTS
MicroCT demonstrated osseous in-growth of native cancellous bone in the trabecular architecture of the 3D-pTi interbody cages and no interaction between the PEEK cages with the surrounding native bone. Qualitative histology revealed robust osseointegration in 3D-pTi implants and negligible osseointegration with localized fibrosis in PEEK implants. Evidence of intramembranous and endochondral ossification was apparent with the 3D-pTi cages. Quantitative histometric bone implant contact demonstrated significantly more contact in the 3D-pTi implants versus PEEK (p<.001); region of interest calculations also demonstrated significantly greater osseous and cartilaginous interdigitation at the implant-native bone interface with the 3D-pTi cages (p=.008 and p=.015, respectively).
CONCLUSIONS
3D-pTi interbody cages without bone graft outperform PEEK interbody cages with AICBG in terms of osseointegration at 4 and 8 weeks postoperatively in an ovine lumbar fusion model.
CLINICAL SIGNIFICANCE
3D-pTi interbody cages demonstrated early and robust osseointegration without any bone graft or additive osteoinductive agents. This may yield early stability in anterior lumbar arthrodesis and potentially bolster the rate of successful fusion. This could be of particular advantage in patients with spinal neoplasms needing post-ablative arthrodesis, where local autograft use would be ill advised.
Identifiants
pubmed: 34906741
pii: S1529-9430(21)01057-3
doi: 10.1016/j.spinee.2021.12.004
pii:
doi:
Substances chimiques
Benzophenones
0
Ketones
0
Polymers
0
polyetheretherketone
31694-16-3
Polyethylene Glycols
3WJQ0SDW1A
Titanium
D1JT611TNE
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
1016-1027Informations de copyright
Copyright © 2021 Elsevier Inc. All rights reserved.
Déclaration de conflit d'intérêts
Declarations of competing interests This study received grant funding through Spineart SA (Geneva, Switzerland). Spineart SA is the manufacturer of the tested implant devices in which this study sought to evaluate. The results from this manuscript were presented in abstract form at 35th Annual Meeting of the North American Spine Society on 1 September 2020. The manuscript has not been previously published nor is it under review in any other journal. No known or perceived conflicts of interest exist amongst any of the authors regarding the material presented within this manuscript, with the exception of Dr. Joseph Laratta, MD who reports the following in the interest of full disclosure: consulting roles with Stryker/K2M, NuVasive, 4Webb, Spineart, Evolution Spine, and Gerson Lehrman Group; receives royalties from Spineart, Evolution Spine, has intellectual property with Combination biologic and ICBG/BMAC system; receives grants from Medtronic, NuVasive, Stryker/K2M, Orthopaedic Science Research Foundation; receives travel and accommodations from American Institute of Minimally Invasive Surgery, NuVasive, Stryker/K2M, Spineart, Fisher Owen Fund; serves on the editorial board of Spine, Global Spine Journal, and Journal of Spine Surgery.